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Abstract. An activity–guided fractionation was used to identify the antileishmanial compounds of Corymbia
maculata. The hexane, ethyl acetate and methanol extracts were active in in vitro antileishmanial assay.
Twelve polyphenols including 8-demethyl eucalyptin (1), eucalyptin (2), myrciaphenone A (3), myrciaphe-
none B (4), quercetin-3-O-β-D-xylopyranoside (5), myricetin-3-O-α-L-rhamnopyranoside (6), quercetin-3-
O-β-D-galactopyranoside (7), quercetin-3-O-β-D-glucopyranoside (8), quercetin-3-O-α-L-rhamnopyranoside
(9), syringic acid (10), gallic acid-3-methyl ether (11), gallic acid-4-methyl ether (12) and gallic acid (13)
were isolated from the active extracts. All the tested compounds except 8-demethyleucalyptin and myrciaphe-
none B showed strong to moderate (6.9–24.5 μM) antileishmanial activity against Leishmania donovani pro-
mastigotes. An HPLC-PDA method has been developed to detect/quantify 29 compounds in the extracts of
C. maculata leaves. This validated method allows simultaneous quantitation of seven flavonoids, four-
teen phloroglucinols and eight other polyphenols and can be applied for qualitative as well as quantitative
determination of phytoconstituents in Eucalyptus matrices.
Keywords. Corymbia maculata; flavonoid glycosides; methylated flavonoids; myrciaphenone; HPLC
quantitation.
1. Introduction
Leishmaniasis, one of the world’s most neglected dis-
eases, is endemic in 88 countries with more than
350 million people at risk.1 During the last few years,
we have focused our interest on isolation and synthe-
sis of potential antileishmanial molecules.2–4 In search
of more bioactive constituents, we have investigated
Corymbia maculata (Hook.) K D Hill and L A S
Johnson (Syn: Eucalyptus maculata). Though seve-
ral members of this genus have been the subject of
extensive phytochemical and pharmacological research,
reports of investigations on C. maculata are very few.
Some methylated flavonoids isolated from C. maculata
leaf extracts have shown antibacterial activity.5
In this paper, we report isolation of flavonoids
and phenolics including 8-demethyl eucalyptin (1), 6
eucalyptin (2),6 myrciaphenone A (3),7 myrciaphe-
none B (4),8 quercetin-3-O-β-D-xylopyranoside (5), 9
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myricetin-3-O-α-L-rhamnopyranoside (6), 10 quercetin-
3-O-β-D-galactopyranoside (7), 9 quercetin-3-O-β-D-
glucopyranoside (8),9 quercetin-3-O-α-L-rhamnopyra-
noside (9),9 syringic acid (10),11 gallic acid-3-methyl
ether (11),12 gallic acid-4-methyl ether (12)13 and
gallic acid (13)14 (figure 1) from the extracts of leaves
of C. maculata.
In addition, an RP-HPLC method was developed
to detect and/or quantify formylated phloroglucinols
and other compounds including flavonoids and sim-
ple phenols in the extracts of C. maculata. Although
there have been several studies of the chemosystem-
atics of the genus Eucalyptus, there are very few
analytical methods available to simultaneously deter-
mine (qualitatively or quantitatively) the compounds
belonging to diverse structural categories. The pro-
posed HPLC method enables determination of eight
formylated phloroglucinol compounds (including two
monomerics, one dimeric and five euglobals), six ‘non-
formylated’ phloroglucinols (including a monomer, two
phloroglucinol glycosides and three triketones), seven
flavonoids and eight other polyphenols.
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2. Materials and methods
2.1 General
All chemicals and solvents used for extraction and
purification were of laboratory reagent grade. All chro-
matographic purifications were performed with silica
gel #60–120 and silica gel G whereas all TLC analy-
sis was performed on silica gel coated (Merck Kiesel-
gel 60 F254, 0.2 mm thickness) plates. HPLC grade
ethyl acetate, acetonitrile, methanol, formic acid, acetic
acid and trifluoroacetic acid (JT Baker) and ultra pure
water (Elga R©) were used for sample preparation and in
HPLC mobile phases.
Apart from the chemical markers isolated from
C. maculata (1–13), the standards i.e., protocatechuic
acid (14), chlorogenic acid (15), caffeic acid (16),
2-hydroxycinnamic acid (17) were a kind gift from
Prof. R C Gupta of University of Louisville, USA.
Miniatone (20), grandinol (21), 8-demethyl kalmiatin
(22), jensenone (23), euglobal G1 (25), sideroxylonal
A (26), euglobal G2 (27), euglobal Bl-1 (28), euglobal
G3 (29), euglobal G4 (30) were isolated from differ-
ent sources.4,15 Syncarpic acid (18), flavesone (19) and
leptospermone (24) were synthesized from phlorogluci-
nol (for structures, see figure 1). All the standards were
≥98% pure by HPLC and NMR.
2.2 Plant material
The plant material was collected from four individual
trees at the Australian National University coastal cam-
pus Kioloa, New South Wales, Australia. The leaves
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Figure 1. Structures of compounds 1–30.
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were air-dried in the shade, crushed coarsely and stored
at −20◦C until extraction.
2.3 Equipment and apparatus
The HPLC analysis was carried out on C18 column
(Phenomenex, 250 × 4.6 mm, 5 μ, 100 Å) connected
to a Shimadzu HPLC system consisting of a model
LC–10AT VP fitted with a SIL–20AC autosampler and
SPD–M10A VP photodiode array detector. Princeton
SPHER-C18 column (250 × 10 mm, 5 μ, 100 Å) was
used for isolation of compounds.
Isolation of compounds was also done using C18
column (Luna, 250 × 30 mm, 10 μ, 100 Å) connected
to a preparative HPLC system (Shimadzu, CBM-20A)
equipped with a LC–8A binary gradient pump, an SPD–
20AV UV-Vis detector, an FRC–10A fraction collector
and a recycle valve.
IR spectra were taken on FT-IR spectrometer
(Nicolet, USA). Mass spectra were recorded on a
GCMS-QS (Shimadzu, Japan). 1H and 13C NMR spec-
tra were recorded on 400 and 100 MHz spectrometers
(Bruker), respectively.
2.4 Extraction and isolation
Dried and crushed leaves (2 kg) of C . maculata were
extracted in a macerator (20 L capacity) with hexane
(5 L × 5) for 48 h. The extract was filtered to remove
any plant particles and was concentrated on rotary
evaporator to yield 47 g of thick yellowish-green tar.
Similarly, leaves were sequentially extracted with
solvents in increasing polarity to yield 42 g of
dichloromethane, 56 g of ethyl acetate and 80 g of
methanol extract.
Light yellow crystals separated out of hexane extract
while it was being concentrated. These were washed
several times with cold hexane and dried. This fraction
(7.8 g) showed only one major spot apart from chloro-
phylls on normal phase TLC developed with hexane–
DCM (1:1). It was subjected to charcoal treatment to
remove plant pigments. A portion (100 mg) of this frac-
tion was subjected to semi-preparative HPLC [column:
C18, 250 × 10 mm; mobile phase: methanol–0.3% aque-
ous trifluoroacetic acid (9:1); Flow rate: 3.5 mL.min−1;
detection: 328 nm] to yield compound 1 (17 mg) and
compound 2 (52 mg).
Methanol extract (80 g) was partitioned into
dichloromethane (trace), ethyl acetate (20 g) and
butanol (55 g) soluble fractions. The butanol–soluble
fraction was chromatographed over silica gel #60–120
[column H: 30 cm, i.d.: 7 cm; eluant: hexane-ethyl
acetate (0% to 90% EtOAc) then chloroform–
methanol gradients (1% to 50% MeOH)] to yield 15
sub-fractions.
Pooled sub-fractions 5 and 6 (6.3 g, eluted with
5–10% methanol in chloroform) were subjected to
gel permeation chromatography over Sephadex LH20
using methanol to obtain six pools of different TLC
profiles. Pools 3 and 4 (1.0 g) were subjected to
recycle prep-HPLC [column: C18, 250 × 30 mm;
mobile phase: methanol-water-acetic acid (30:69:1);
flow rate: 40 mL.min−1; detection: 284 nm] to obtain
compounds 3 (880 mg) and 4 (18 mg). Pool 5 (800 mg)
stained yellow to orange with natural products (NP)
reagent revealing the presence of flavonoids. Repetitive
and recycle chromatography of this fraction [column:
C18, 250 × 30 mm; mobile phase: methanol-water-
acetic acid (40:59:1); flow rate: 40 mL.min−1; detec-
tion: 350 nm] gave compounds 5 (17 mg), 6 (55 mg),
7 (20 mg), 8 (5 mg) and 9 (145 mg).
Pooled sub-fractions 8 and 9 (16.3 g, eluted with
20% methanol in chloroform) were subjected to gel per-
meation chromatography over Sephadex LH20 using
methanol to obtain 5 fractions. Fraction 3 (2.95 g)
presented two major spots (giving intense blue fluores-
cence with NP reagent) on normal phase TLC deve-
loped with toluene-ethyl acetate-acetic acid (5:4.5:0.5).
A portion of this fraction was rechromatographed over
Sephadex LH20 using methanol–water (1:1) to yield
compounds 10 (25 mg), 11 (48 mg), 12 (13 mg) and
13 (1.1 g).
2.4a Compound 1: Light yellow crystals, IR (Neat):
νmax 3391, 2923, 2953, 2868, 1605, 1459, 1376, 1219,
1054 cm−1; APCI MS: m/z 313 [M+1]+, 298, 236,
165; 1H and 13C NMR (400 MHz, CDCl3): see table 1a.
2.4b Compound 2: Light yellow needles; IR (Neat):
νmax 3400, 2924, 2851, 1634, 1459, 1376, 1219,
1053 cm−1; APCI MS: m/z 327 [M+1]+, 313 [M-
CH3]+, 236, 165; 1H and 13C NMR (400 MHz, CDCl3):
see table 1a.
2.4c Compound 3: Off white solid; IR (Neat): νmax
3368, 2946, 2833, 1654, 1453, 1414, 1114, 1032,
668 cm−1; APCI MS: m/z 353 [M+Na]+, 316, 302,
202 [sugar+Na]+, 168; 1H and 13C NMR (400 MHz,
CD3OD): see table 1a.
2.4d Compound 4: Light brown solid; IR (Neat):
νmax 3435, 2973, 2923, 2866, 1638, 1360, 1054,
1033, 1016, 766 cm−1; APCI MS: m/z 505 [M+Na]+,
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Table 1a. 1H (δ ppm, multiplicity, J in Hz) and 13C (δ ppm) NMR data of compounds 1–4.
1 2 3 4
Position δC δH δC δH δC δH δC δH
1 105.3 105.5
2 163.4 162.6 164.8 161.2
3 105.3 6.59, s 107.4 6.61, s 100.6 6.18, d, 2.0 94.3 6.16, s
4 182.4 183.2 166.3 165.0
5 158.5 157.3 93.9 5.94, d, 2.0 97.0 5.94, s
6 114.1 114.1 161.2 166.2
7 163.6 163.9 203.4 203.4
8 89.3 6.49, s 104.1 32.1 2.68, s 32.0 2.67, s
9 155.9 152.9
10 109.1 108.8
1′ 123.8 123.9 96.7 5.01, d, 7.4 100.8 5.07, d, 7.6
2′ 127.9 7.84, d, 8.0 127.9 7.86, d, 8.4 73.3 3.72, dd, 73.3 3.75–3.48, m
12.0, 5.2
3′ 114.5 7.01, d, 8.8 114.5 7.02, d, 8.4 77.1 3.55–3.34, m 76.8
4′ 162.5 162.6 69.7 69.7
5′ 114.5 7.01, d, 8.8 114.5 7.02, d, 8.4 76.9 74.4
6′ 127.9 7.84, d, 8.0 127.9 7.86, d, 8.4 60.9 3.91, dd, 62.9 4.55, d, 12.0
12.0, 1.6 and 4.45, dd,
12.0, 4.4
1′′ 119.8
2′′ 108.8 7.10, s
3′′ 145.1
4′′ 138.5
5′′ 145.1
6′′ 108.8 7.10, s
7′′ 166.9
7/4′–OCH3 55.9/55.5 3.89/3.92, s 60.5/55.5 3.89/3.79, s
6/8–CH3 7.3 2.11, s 8.5/8.2 2.39/2.21, s
482 [M]+, 315; 1H and 13C NMR (400 MHz, CD3OD):
see table 1a.
2.4e Compound 5: Yellow solid; IR (Neat): νmax
3411, 2950, 2844, 1642, 1053, 1032, 1016 cm−1; APCI
MS: m/z 457 [M+Na]+, 303 [M-sugar]+; 1H and 13C
NMR (400 MHz, CD3OD): see table 1b.
2.4f Compound 6: Light yellow solid; IR (Neat):
νmax 3368, 2946, 2833, 1654, 1453, 1415, 1116, 1031,
667 cm−1; APCI MS: m/z 487 [M+Na]+, 464 [M]+,
319 [M-sugar]+; 1H and 13C NMR (400 MHz, CD3OD):
see table 1b.
2.4g Compound 7: Yellow solid; IR (Neat): νmax
3433, 2920, 1745, 1683, 1598, 1053, 1075 cm−1; APCI
MS: m/z 487 [M+Na]+, 465 [M+1]+, 303 [M-sugar]+;
1H and 13C NMR (400 MHz, CD3OD): see table 1b.
2.4h Compound 8: Yellow solid; IR (Neat): νmax
3433, 2920, 1745, 1683, 1598, 1053, 1075 cm−1; APCI
MS: m/z 487 [M+Na]+, 465 [M+1]+, 303 [M-sugar]+;
1H and 13C NMR (400 MHz, CD3OD): see table 1b.
2.4i Compound 9: Light yellow solid; IR (Neat):
νmax 3435, 2972, 2844, 1645, 1372, 1054, 1032,
1015, 772 cm−1; APCI MS: m/z 471 [M+Na]+, 449
[M+H]+, 303 [M-sugar]+; 1H and 13C NMR (400 MHz,
CD3OD): see table 1b.
2.4j Compound 10: Colourless needles (MeOH); IR
(Neat): νmax 3474, 2941, 1698, 1617, 1521, 1372, 1203,
1177, 1113 cm−1; APCI MS: m/z 181 [M–OH]+, 154;
1H NMR (400 MHz, CD3OD): δ 7.33 (2H, s, H–2, –6),
3.88 (6H, s, 3, 5–OCH3); 13C NMR (100 MHz,
CD3OD): δ 170.1 (–COOH), 148.8 (C–3, –5), 141.7
(C–4), 121.9 (C–1), 108.3 (C–2, –6), 56.8 (3, 5-OCH3).
2.4k Compound 11: Light yellow needles (MeOH);
IR (Neat): νmax 3434, 2920, 1660, 1613, 1346, 1313,
1255, 1111, 1082 cm−1; APCI MS: m/z 167 [M–OH]+;
1H NMR (400 MHz, CD3OD): δ 7.11 (1H, s, H-2),
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Table 1b. 1H (δ ppm, multiplicity, J in Hz) and 13C NMR (δ ppm) data of compounds 5–9.
5 6 7 8 9
Position δC δH δC δH δC δH δC δH δC δH
2 157.0 158.0 156.7 158.5 157.1
3 134.0 134.9 133.9 135.7 134.8
4 178.0 178.2 177.9 179.5 179.6
5 161.6 161.8 156.6 159.1 157.9
6 98.5 6.20, s 98.4 6.19, s 99.1 6.22, s 100.0 6.22, s 98.4 6.20, s
7 164.6 164.5 164.6 166.0 164.5
8 93.3 6.39, s 93.3 6.36, s 93.9 6.43, s 94.9 6.42, s 93.3 6.37, s
9 157.5 157.1 161.7 162.9 161.8
10 104.2 104.4 104.3 105.7 104.5
1′ 121.6 120.5 121.5 123.1 121.4
2′ 114.6 7.58, d, 8.8 108.1 7.00, s 115.6 7.84, s 116.1 7.71, s 114.9 7.33, s
3′ 144.6 145.4 145.3 145.9 145.0
4′ 148.5 136.5 148.9 149.9 148.4
5′ 115.8 6.86, d, 8.4 145.4 116.4 6.88, d, 8.8 117.7 6.88, d, 8.4 115.5 6.90, d, 8.0
6′ 121.9 7.61, s 108.1 7.00, s 122.4 7.59, d, 8.7 123.3 7.59, d, 8.4 121.5 7.30, d, 8.4
1′′ 103.2 5.17, d, 7.2 102.2 5.32, s 102.2 5.17, d, 8.0 104.5 5.24, d, 7.2 102.1 5.34, s
2′′ 73.8 3.51–3.41, m 70.5 4.23, s 71.6 3.56, m 75.8 3.47–3.35, m 70.5 4.21, s
3′′ 69.6 70.6 3.79, d, 8.4 76.3 78.4 70.6 3.74, dd, 9.2, 1.2
4′′ 76.1 71.9 3.34, m 68.4 3.48, m 71.3 71.8 3.45–3.38, m
5′′ 65.8 3.78, dd, 11.5, 70.7 3.52, m 73.6 3.35, m 78.1 3.22, m 70.7
5.1 and 3.10, m
6′′ 16.3 0.98, d, 6.4 60.6 3.83, m and 62.6 3.73, m and 16.2 0.94, d, 6.0
3.64, m 3.57, m
7.09 (1H, s, H-6), 3.78 (3H, s, 3–OCH3); 13C NMR
(100 MHz, CD3OD): δ 170.4 (–COOH), 149.1 (C–3),
146.1 (C–5), 140.5 (C–4), 121.9 (C–1), 112.2 (C–6),
106.3 (C–2), 56.8 (3-OCH3).
2.4l Compound 12: Light yellow needles (MeOH);
IR (Neat): νmax 3374, 1698, 1613, 1535, 1443, 1329,
1260, 1212, 1053 cm−1; APCI MS: m/z 167 [M–OH]+;
1H NMR (400 MHz, CD3OD): δ 7.03 (2H, s, H–2, –6),
3.80 (3H, s, 4-OCH3); 13C NMR (100 MHz, CD3OD):
δ 169.1 (–COOH), 146.5 (C–3, –5), 139.8 (C–4), 121.4
(C–1), 110.1 (C–2, –6), 52.4 (4-OCH3).
2.4m Compound 13: Off white solid; APCI MS m/z
169 [M–H]+, 1H NMR (400 MHz, CD3OD, δ ppm):
7.05 (s, 2H); 13C NMR (75 MHz, CD3OD, δ ppm):
172.4, 145.1, 138.3, 120.4, 108.6.
2.5 In vitro antileishmanial activity
The MTT viability assay was performed as described
previously.16 Briefly, approximately 2 × 105 L. dono-
vani promastigotes were plated in 200 μL of RPMI-
1640 media (pH 7.2) in a flat-bottom 96-well cul-
ture microplate. Plate was incubated for 48 h at 24◦C.
Compounds were added to the wells at different
concentrations and the plate was again incubated for
48 h at 24◦C. MTT solution was added to each well to a
final concentration of 400 μg/mL, and the plates were
incubated for 3–4 h at 37◦C. Cells were centrifuged at
3,000 g for 10 min. Pellets were dissolved in 150 μL
of dimethyl sulphoxide (DMSO) and further incubated
for 15 min. The absorbance was read on an automated
microplate reader (Powerpack 200; Biotek Instruments)
at 540 nm.
2.6 HPLC analyses
2.6a Sample preparation: A sample (30 g) of the
dried leaves of C. maculata was placed in a Soxhlet
extraction thimble and sequential extraction was car-
ried out with n-hexane, dichloromethane, ethyl acetate
and methanol for 24 h with each solvent. The extracts
obtained were filtered to remove any plant parti-
cles and concentrated under vacuum to yield hexane,
dichloromethane, ethyl acetate and methanol extracts.
For HPLC analysis, hexane, dichloromethane and
ethyl acetate extracts were dissolved in acetonitrile:
ethyl acetate (1:1) and the methanol extract was dis-
solved in methanol to make a concentration of 1 mg/mL
and filtered through a 0.45 μ PTFE syringe filter.
Five μL of each extract was injected onto the HPLC
column using an autosampler.
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2.6b Chromatographic conditions: Appropriate sepa-
ration was achieved on C18 Phenomenex (250×4.6 mm,
5 μ) column with a gradient of ACN (solvent A), water
containing 2% formic acid (solvent B) and ACN con-
taining 1% formic acid (solvent C) using the follow-
ing program: 0–10 min 5% A in B, 10–12 min 20%
A in B, 12–20 min 20% A in B, 20–25 min 30% A
in B, 25–30 min 40% A in B, 30–35 min 50% A in
B, 35–45 min 60% A in B, 45–65 min 75% A in B,
65–70 min 100% C, 70–85 min 100% C, 85–87 min 5%
A in B, 87–95 min 5% A in B. The flow rate was set at
1.5 mL/min and the analytes were detected at 280 nm.
Sample injection volume was 5 μL.
2.6c Validation of HPLC method: Stock solutions
(1 mg/mL) of standards (1–7, 9–30) were prepared in
ethyl acetate–acetonitrile (1:1) and diluted to appro-
priate concentrations for establishment of calibration
curves. Six concentrations of the 29 standards were
injected in triplicate and the calibration curves were
constructed by plotting the peak areas against the con-
centration of each analyte.
The limit of detection (LOD) and limit of quantifi-
cation (LOQ) under the above stated chromatographic
conditions were determined on the basis of response at
a signal-to-noise ratio (S/N) of 3 and 10, respectively.
Intra- and inter-day variations were used to determine
the precision of the HPLC method. A sample of 30 g
of dried leaves of C. maculata was extracted and ana-
lysed as described in the sections above. Intra-day preci-
sion was performed by triplicate extraction and analysis
on a single day. The inter-day precision was carried
out on 3 different days. Variations were expressed as
the relative standard deviations (RSD). The recovery
test was used to evaluate the accuracy of this quan-
titation method. Accurate amounts of the 29 analytes
were added to known amounts of ethyl acetate extract
that was then dissolved in ethyl acetate–acetonitrile
(1:1) and analysed. The average recoveries were calcu-
lated by the following formula: recovery (%) = 100 ×
(amount found–original amount)/amount spiked, with
RSD (%) = (SD/mean) × 100%.
3. Results and discussion
3.1 Isolation, characterization and antileishmanial
activity
The in vitro antileishmanial activity of n-hexane,
dichloromethane, ethyl acetate and methanol extracts
of C. maculata prepared by sequential macera-
tion revealed that the hexane and methanol extracts
were active (IC50 7.0 and 7.1 μg/mL, respectively),
ethyl acetate extract was moderately active (IC50
13.0 μg/mL) and the chloroform extract was inactive.
Compounds 1 and 2 were obtained after semi-
preparative HPLC of yellowish crystals separated out
of hexane extract of C. maculata leaves. 1H and 13C
NMR of the two compounds were very similar and the
molecular ion peaks in APCI MS showed a difference
of 15 units indicating the loss of one methyl group.
The 1H NMR spectrum of 1 revealed the presence of
a H-bonded hydroxyl group, a para substituted B ring,
one aromatic A ring proton, two methoxyl groups and
one C-methyl substituent. The combined information
from the 1H and 13C NMR data confirmed that 1 was a
flavone, unsubstituted in 3-position (δH 6.59, δC 105.3).
Ring B protons appeared as two doublets, for two
protons each (δ 7.84 and 7.01) in 1H NMR. This com-
pound was identified as 5-hydroxy-7,4′-dimethoxy-6-
methylflavone (8-demethyl eucalyptin). In the spectral
data of 2, an additional signal for a C-methyl group
(δH 2.39) appeared and the signal of the aromatic ring
A proton (δH 6.49) disappeared. Also, the signal for
C-8 was shifted downfield (δC 89.3 in 1 and 104.1 in
2). The structure of this compound was determined
to be 5-hydroxy-7,4′-dimethoxy-6,8-dimethylflavone
(eucalyptin).
Compound 3 was isolated as off-white solid from the
methanol extract of leaves of C . maculata. A sodiated
molecular ion peak was observed at m/z 353 [M+Na]+.
A fragment peak due to loss of one methyl was present
at m/z 316 [C13H15O9+H]+. Another fragment peak at
m/z 202 showed the presence of sodium adduct of a
hexose sugar [C6H11O6Na]+. The IR absorption band at
3368 cm−1 indicated the presence of hydroxyl groups
and the absorption band at 1654 cm−1 was indicative
of a keto group. The signal of a quaternary carbon
at δ 203.4 in 13C NMR spectrum confirmed the pres-
ence of a keto function in the molecule. 13C NMR
also showed signals due to phloroglucinol aromatic ring
(between δC 95–166) and an acetyl group. The 1H NMR
spectrum presented two aromatic protons (δ 6.18, d,
J = 2.0 Hz and 5.94, d, J = 2.0 Hz) meta to each
other. The presence of six 13C NMR signals between
δ 60 to 105 were attributable to an O-glycosidically
linked hexose residue. The hexose residue was con-
sidered to be β-D-glucopyranose because the chemical
shifts of sugar carbon were in agreement with litera-
ture data.7 The coupling constant of anomeric proton
(J = 7.4 Hz) confirmed β configuration. Acidic hydro-
lysis of 3 gave glucose which was identified by compar-
ison of TLC with an authentic sample. The spectrum
indicated that C–2 and C–6 were non-equivalent, i.e.,
signals at δ 164.8 and 161.2, respectively. The H–3
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(C–3) and H–5 (C–5) signals were also non-equivalent,
i.e., signals at δ 6.18 (100.6) and 5.94 (93.9), respec-
tively. This compound was characterized as 4,6-
dihydroxy-2-O-(β-D-glucopyranosyl)acetophenone or
myrciaphenone A.
Another compound (4) was isolated as a very minor
component from the fractions containing myrciaphe-
none A. The spectral data of 4 indicated a close struc-
tural resemblance between the two compounds. 1H and
13C NMR showed signals for phloroacetophenone core
as in myrciaphenone A. The presence of a galloyl group
in the structure of 4 was suggested by a two proton
singlet at δ 7.10 in 1H NMR and four characteristic
carbon signals (δ 108.8, 119.8, 145.1, 166.9) in 13C
NMR spectrum. The resonances between δ 3.48 and
δ 4.45 were assigned to the protons of sugar moiety.
The coupling constant of the anomeric proton (δ 5.07,
d, J = 7.6 Hz) in the 1H NMR spectrum indicated β
configuration and from the other chemical shifts and
coupling constants of the sugar moiety, it was clear
that the sugar unit was β-D-glucopyranose. A consid-
erable downfield shift in the signals of H–6′ (δ 4.55
and 4.45) of sugar moiety indicated the possible place-
ment of galloyl functionality at C–6′ position. Finally,
the HMBC spectrum ascertained the correlation of H–
6′ of the β-glucose moiety with C–1′′ of galloyl subunit.
The structure of 4 was confirmed to be 4,6-dihydroxy-
2-O-[β-D-(6′′-galloyl)glucopyranosyl]acetophenone or
myrciaphenone B.8
The other isolated compounds were characterized
as quercetin-3-O-β-D-xylopyranoside (5), myricetin-
3-O-α-L-rhamnopyranoside (6), quercetin-3-O-β-D-
galactopyranoside (7), quercetin-3-O-β-D-glucopyranoside
(8), quercetin-3-O-α-L-rhamnopyranoside (9), syringic
acid (10), gallic acid-3-methyl ether (11), gallic acid-4-
methyl ether (12) and gallic acid (13) after the compa-
rison of their physico-chemical and spectroscopic data
with that reported in the literature (for 1H and 13C NMR
data of compounds 1–9 refer table 1a and 1b). Except
for compounds 1 and 2, all the other compounds are
reported for the first time from this species.
Isolated flavonoids and phenolic glycosides were
evaluated for their antileishmanial activity in vitro. The
results (table 2) of this assay suggested that glycosy-
lation was necessary for high activity. The flavonoid
glycosides (6–9) were more active than the other com-
pounds tested whereas aglycones, 1 and 2 were inac-
tive and less active, respectively. Amongst the flavonoid
glycosides, compound 5, where the glycone portion
was a deoxy sugar i.e., xylose was much less active
than the compounds containing D-glucose, D-galactose
and L-rhamnose. In the case of myrciaphenone A (3)
and B (4), the inhibition of promastigotes shown by 3
Table 2. In vitro antileishmanial activity of compounds
isolated from C. maculata extracts.*
Compound IC50 (μM)
8-Demethyl eucalyptin (1) NA
Eucalyptin (2) 11.0 ± 1.4
Myciaphenone A (3) 10.0 ± 1.4
Myciaphenone B (4) NA
Quercetin-3-O-β-D-xylopyranoside (5) 24.5 ± 7.7
Myricetin-3-O-α-L-rhamnopyranoside (6) 7.5 ± 2.1
Quercetin-3-O-β-D-galactopyranoside (7) 6.9 ± 0.3
Quercetin-3-O-β-D-glucopyranoside (8) 7.25 ± 0.3
Quercetin-3-O-α-L-rhamnopyranoside (9) 8.5 ± 4.9
Miltefosine (Std.) 10.0 ± 3.0
*Results are expressed as mean ± SD of two independent
experiments performed in triplicate
NA: Not active
was equivalent to that of the standard drug miltefosine
whereas 4, the galloylated counterpart of 3 was com-
pletely inactive, again suggesting a possible role of the
sugar moiety in the bioactivity of compounds in this
assay.
3.2 HPLC analyses
3.2a Preparation of extracts: The extraction condi-
tions and related parameters can lead to significant
differences and variations in any quantitative analy-
ses. Therefore, it was important to select one specific
method of extraction for the phytochemical analysis of
C. maculata. Sequential Soxhlet extraction was chosen
for preparing extracts as it promised maximum extrac-
tion of the compounds of low, medium and high polari-
ties. From a 30 g sample of dried leaves of C. maculata,
906 mg of hexane, 1231 mg of chloroform, 1107 mg
of ethyl acetate and 3689 mg of methanol extracts,
respectively, were obtained after sequential Soxhlet
extraction.
3.2b Optimization of HPLC conditions: Recently,
we have reported an HPLC–PDA method for simulta-
neous quantitation of 19 compounds belonging to dif-
ferent chemical classes to facilitate quantitative com-
parison amongst eucalypts.15 This method used a gradi-
ent of acetonitrile and 2% aqueous formic acid for the
separation of compounds. In the present study, we have
improved upon that method to incorporate more plant
constituents so as to increase the applicability of the
method. Some of the phenolic acids (10–13) were iso-
lated from the methanol extract of C. maculata, so, the
gradient program was modified to detect/quantify more
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compounds of this class (15–17). Particularly, the ini-
tial ratio of the stronger solvent i.e., ACN was reduced
and gradient time was increased so that highly polar
phenolic acids could be separated.
After trying several solvent systems and gradients, a
solvent system consisting of ACN (solvent A), water
with 2% formic acid (solvent B), ACN with 1% formic
acid (solvent C) in gradient mode (as described in ‘chro-
matographic conditions’) was found to be optimum. Ini-
tially, a binary gradient of A and B was used from 0 to
65 min. This gradient allowed the separation of euca-
lyptin (2), a methylated flavonoid and jensenone (23),
a formylated phloroglucinol which, despite their struc-
tural differences, were eluting at same RT in several
other solvent systems and gradient programs (though
baseline resolution was not achieved in this gradient
but owing to the differences in λmax, 328 for eucalyptin
and 266 for jensenone, qualitative analysis of samples
containing both the compounds was possible). From 65
to 70 min, the proportions of solvents A and B were
decreased and that of C was increased until 100% at
70 min. The 100% concentration of C was maintained
for 15 min. This allowed the resolution of euglobals (25,
27–30) and sideroxylonal A (26) that otherwise was not
(a)
(b)
(c)
Figure 2. HPLC chromatogram (at 280 nm) of (a) mixed standard solution, 13: gal-
lic acid (4.63 min); 14: protocatechuic acid (9.76 min); 11: gallic acid-3-methyl ether
(13.52 min); 15: chlorogenic acid (16.60 min); 12: gallic acid-4-methyl ether (16.78 min); 3:
myrciaphenone A (17.04 min); 16: caffeic acid (17.63 min); 10: syringic acid (18.03 min);
4: myrciaphenone B (19.53 min); 9: quercetin-3-O-α-L-rhamnopyranoside (20.60 min);
7: quercetin-3-O-β-D-galactopyranoside (21.00 min); 5: quercetin-3-O-β-D-xylopyranoside
(22.8 min); 6: myricetin-3-O-α-L-rhamnopyranoside (25.50 min); 17: 2-hydroxy cinnamic
acid (26.88 min); 18: syncarpic acid (30.08 min); 19: flavesone (50.99 min); 20: minia-
tone (52.43 min); 1: 8-demethyl eucalyptin (55.27 min); 21: grandinol (56.63 min); 22: 8-
demethyl kalmiatin (58.39 min); 2: eucalyptin (58.88 min); 23: jensenone (59.14 min); 24:
leptospermone (63.06 min); 25: euglobal G1 (77.52 min); 26: sideroxylonal A (77.79 min);
27: euglobal G2 (78.36 min); 28: euglobal Bl-1 (78.95 min); 29: euglobal G3 (79.32 min) and
30: euglobal G4 (80.09 min); (b) hexane extract; (c) ethyl acetate extract.
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achieved. Another mobile phase with solvents C and
B (keeping the gradient program same as above) was
tested but eucalyptin and jensenone were eluted as a sin-
gle peak in this system. The gradient program with the
solvents A, B and C was used for all analyses. One dis-
advantage of this method is the co-elution of quercetin-
3-O-β-D-galactopyranoside (7) and quercetin-3-O-β-
D-glucopyranoside (8). For the quantitation of 7 and 8,
calibration curve of 7 was constructed and both 7 and 8
were quantified in total.
3.2c Method validation: The proposed method was
validated to determine the linearity, LOD, LOQ, intra-
and inter-day precisions and accuracy. The calibration
curves for compounds (1–7, 9–13) were obtained with
concentrations in six increments. The correlation coef-
ficient values (r2 = 0.999) indicated the appropriate
correlation between concentration and the correspond-
ing peak areas. LOD and LOQ for all the analytes
were determined by diluting the standard stock solu-
tions of the corresponding compounds sequentially. The
LOD (S/N = 3) and LOQ (S/N = 10) for the com-
pounds quantified were in the range of 3.5–33.4 ng and
12–97.8 ng, respectively (table 3). The HPLC method
developed showed good reproducibility for the quanti-
tation of 12 compounds, with intra- and inter-day vari-
ations of these compounds less than 3.6% (RSD) and
4.6% (RSD), respectively. Also, this method was found
to be accurate with the overall recovery of 91.7–107.7%
(RSD range 0.0–3.22%) (table 3). These results estab-
lish that the developed method is sensitive, precise and
accurate with respect to the plant constituents studied
and can be applied more widely for qualitative and
quantitative analysis of eucalypt matrices.
3.2d Analysis of samples and quantitation: The
extracts of C. maculata leaves prepared by sequen-
tial Soxhlet extraction were analysed by the developed
method. Of the 29 compounds used in method deve-
lopment, only two were detected in hexane and chlo-
roform extracts and ten compounds were found to be
present in ethyl acetate and methanol extracts. The
HPLC chromatogram of 29 mixed standards along with
the chromatograms of hexane and ethyl acetate extracts
are shown in figure 2 and the contents of the detected
constituents in the respective extracts are presented in
table 4.
The results of the HPLC quantitation were consis-
tent with the biological activity results. In the in vitro
antileishmanial assay, hexane and methanol extracts
were most active. In case of hexane extract, demethyl
eucalyptin (1) and eucalyptin (2) were found to be the
major constituents, present at 2.16 and 2.87%, respec-
tively. The methanol extract showed the presence of
active flavonoid glycosides. Myrciaphenone A (3, IC50
10 μM) was found to be the major constituent of the
ethyl acetate extract. Myrciaphenone B could not be
detected in any of the extracts up to a loading of
5000 ng. None of the active (or inactive) compounds
could be detected in the chloroform extract.
3.3 Chemotaxonomical importance of the study
The genus Eucalyptus encompasses about 800 species
grouped into 13 different informal subgenera.17 W E
Hillis studied the variation of the polyphenol content in
different eucalypts as a marker in their chemosystema-
tic studies.18–22 More recently, Eschler et al. asserted
that formylated phloroglucinol compounds (FPCs) are
Table 4. The contents of the studied compounds in three extracts of dry leaves of C. maculata.
Content (%)a
Sl. No. Compound Hexane extract Ethyl acetate extract Methanol extract
1 Gallic acid (13) – 3.17 ± 0.09 1.20 ± 0.03
2 Gallic acid-3-methyl ether (11) – – 1.73 ± 0.06
3 Gallic acid-4-methyl ether (12) – – 1.95 ± 0.01
4 Myrciaphenone A (3) – 8.26 ± 0.78 1.38 ± 0.14
5 Syringic acid (10) – – 2.66 ± 0.03
6 Quercetin 3-O-β-D-rhamnopyranoside (9) – 1.71 ± 0.16 0.41 ± 0.05
7 Quercetin 3-O-β-D-galactopyranoside (7)b – 0.49 ± 0.02 0.46 ± 0.03
8 Quercetin 3-O-β-D-xylopyranoside (5) – 0.32 ± 0.01 0.05 ± 0.01
9 Myricetin 3-O-β-D-rhamnopyranoside (6) – 2.24 ± 0.20 0.40 ± 0.06
10 8-Demethyl eucalyptin (1) 2.16 ± 0.15 – –
11 Eucalyptin (2) 2.87 ± 0.26 – –
aContent = mean ± s.d. (n = 3); btotal content of 7 and 8 based on the calibration curve of quercetin 3-O-β-D-
galactopyranoside (7); –, not detected
Antileishmanial polyphenols from Corymbia maculata 775
found more abundantly in the sub-genera Symphyomyr-
tus and Eudesmia whereas there is a notable lack
of FPCs in the sub-genera Monocalyptus, Idiogenes,
Blakella and several species of Corymbia. 23 So, to con-
firm the presence or absence of FPCs in Corymbia mac-
ulata, we undertook phytochemical investigations of
this plant.
Our results show that there is a complete absence of
the tested FPCs in all four extracts of C. maculata. Also,
none of the tested ‘non-formylated’ phloroglucinols
(miniatone and triketones) could be detected in these
extracts. Though this study was done on a single bulk
sample of C. maculata originating from four individual
trees, it supports the results of earlier experiments done
by Eschler et al. 23
4. Conclusions
The phytochemical screening of C. maculata resulted
in the isolation of thirteen compounds from hexane and
methanol extracts of the dried leaves. Flavonoid gly-
cosides and a phloroglucinol glycoside were the active
antileishmanial compounds. The developed HPLC–
PDA method can be applied for the simultaneous
quantitation of phytoconstituents of different chemical
classes. This method was applied to detect and quantify
twelve compounds in the extracts of C. maculata leaves.
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